A2B adenosine receptor antagonists

Details for Australian Patent Application No. 2004292529 (hide)

Owner Gilead Palo Alto, Inc.

Inventors Kalla, Rao; Marquart, Tim; Li, Xiaofen; Elzein, Elfatih; Zablocki, Jeff

Agent Freehills

Pub. Number AU-B-2004292529

PCT Pub. Number WO2005/051951

Priority 10/719,102 21.11.03 US

Filing date 15 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 14 April 2011

International Classifications

C07D 239/545 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 473/06 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051951 Priority application(s): WO2005/051951

15 October 2009 Alteration of Name

  The name of the applicant has been altered to Gilead Palo Alto, Inc.

14 April 2011 Application Accepted

  Published as AU-B-2004292529

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292533-Method and apparatus for making crystalline pet pellets

2004292526-Flame retardant, additive compositions, and flame retardant polyurethanes